+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Transdermal Drug Delivery System Market Research Report by Type (Transdermal Patches and Transdermal Semisolids), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 231 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4896809
UP TO OFF until Dec 31st 2022
The Global Transdermal Drug Delivery System Market size was estimated at USD 6,369.32 million in 2021, USD 6,663.09 million in 2022, and is projected to grow at a CAGR 4.88% to reach USD 8,478.05 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Transdermal Drug Delivery System to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Transdermal Patches and Transdermal Semisolids. The Transdermal Patches is further studied across Drug-In-Adhesive Patches, Matrix Patches, Microneedle Patches, and Reservoir Membrane Patches. The Transdermal Semisolids is further studied across Gels, Ointments, and Sprays.
  • Based on Application, the market was studied across Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications, Pain Management, and Transdermal Estrogen Therapy.
  • Based on End User, the market was studied across Home Care Settings and Hospitals & Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Transdermal Drug Delivery System market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transdermal Drug Delivery System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Transdermal Drug Delivery System Market, including 3M Company, Bayers AG, Boehringer Ingelheim International GmbH, Endo International, Inc., Glaxosmithkline PLC, Hisamitsu Pharmaceutical Co., Inc., IBSA Farmaceutici Italia Srl, Johnson & Johnson, Katecho, LLC, Lavipharm S.A., Lead Chemical Co.,Ltd., Luye Pharma Group, Manchester BIOGEL, Nitto Denko Corporation, Novartis International AG, Nutriband Inc., Sparsha Pharma International Pvt. Ltd., UCB S.A., and Viatris Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Transdermal Drug Delivery System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transdermal Drug Delivery System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transdermal Drug Delivery System Market?
4. What is the competitive strategic window for opportunities in the Global Transdermal Drug Delivery System Market?
5. What are the technology trends and regulatory frameworks in the Global Transdermal Drug Delivery System Market?
6. What is the market share of the leading vendors in the Global Transdermal Drug Delivery System Market?
7. What modes and strategic moves are considered suitable for entering the Global Transdermal Drug Delivery System Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising Prevalence of Chronic Diseases Coupled with Increasing Geriatric Population
5.1.1.2. Surging Adoption of Third Generation Transdermal Drug Delivery System
5.1.1.3. Growing Technological Advancements in Transdermal Drug Delivery System
5.1.2. Restraints
5.1.2.1. Technical Concerns Over Irritation or Skin Sensitivity
5.1.3. Opportunities
5.1.3.1. Emerging Introduction and Application of Automated Drug Delivery Systems
5.1.3.2. Ongoing Inorganic Growth Strategies Such as Partnerships Between Pharmaceutical Companies and Drug Delivery Vendors
5.1.4. Challenges
5.1.4.1. Probable Risk of Drug Failure and Recalls
5.2. Cumulative Impact of COVID-19
6. Transdermal Drug Delivery System Market, by Type
6.1. Introduction
6.2. Transdermal Patches
6.2.1. Drug-In-Adhesive Patches
6.2.2. Matrix Patches
6.2.3. Microneedle Patches
6.2.4. Reservoir Membrane Patches
6.3. Transdermal Semisolids
6.3.1. Gels
6.3.2. Ointments
6.3.3. Sprays
7. Transdermal Drug Delivery System Market, by Application
7.1. Introduction
7.2. Cardiovascular Diseases
7.3. Central Nervous System Disorders
7.4. Hormonal Applications
7.5. Pain Management
7.6. Transdermal Estrogen Therapy
8. Transdermal Drug Delivery System Market, by End-user
8.1. Introduction
8.2. Home Care Settings
8.3. Hospitals & Clinics
9. Americas Transdermal Drug Delivery System Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transdermal Drug Delivery System Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Transdermal Drug Delivery System Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.2. Bayers Ag
13.3. Boehringer Ingelheim International GmbH
13.4. Endo International, Inc.
13.5. GlaxoSmithKline plc
13.6. Hisamitsu Pharmaceutical Co., Inc.
13.7. Ibsa Farmaceutici Italia Srl
13.8. Johnson & Johnson
13.9. Katecho, LLC
13.10. Lavipharm S.A.
13.11. Lead Chemical Co.,Ltd.
13.12. Luye Pharma Group
13.13. Manchester Biogel
13.14. Nitto Denko Corporation
13.15. Novartis International Ag
13.16. Nutriband Inc.
13.17. Sparsha Pharma International Pvt. Ltd.
13.18. Ucb S.A.
13.19. Viatris Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET DYNAMICS
FIGURE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, 2019-2027 (USD MILLION)
FIGURE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 30. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2027
FIGURE 32. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 43. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2027
FIGURE 45. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 47. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 59. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2027
FIGURE 61. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 63. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2027
FIGURE 65. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 79. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2027
FIGURE 80. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 82. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 83. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 92. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 22. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 78. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2019-2027 (USD MILLION)
TABLE 79. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 83. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 84. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 88. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 90. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 91. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 92. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 93. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 95. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 96. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 97. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 99. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 100. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 101. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 103. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 104. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 105. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 107. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 108. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 109. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 111. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 112. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 113. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 114. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 115. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 116. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 117. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 118. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 119. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 121. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 122. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 123. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 125. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 126. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 127. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 128. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 129. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 130. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 131. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 132. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 133. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 134. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 135. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 136. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 137. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 138. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 139. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 140. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 141. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 142. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 143. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 144. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 145. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 146. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 147. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 148. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 149. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 150. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 151. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 152. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 153. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 154. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 155. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 156. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 157. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 158. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 159. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 160. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 161. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 162. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 168. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 170. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 171. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 172. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 173. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 174. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 175. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 176. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 177. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 178. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 179. ITALY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 180. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 181. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 182. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 183. NETHERLANDS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 184. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 185. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 186. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 187. QATAR TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 188. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 189. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 190. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 191. RUSSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 192. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 193. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 194. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 195. SAUDI ARABIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 196. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 197. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 198. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 199. SOUTH AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 200. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 201. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 202. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 203. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 208. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 209. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 210. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 211. UNITED KINGDOM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 212. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 213. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 214. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 215. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET RANKING
TABLE 216. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2021
TABLE 217. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET MERGER & ACQUISITION
TABLE 218. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 219. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 220. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET INVESTMENT & FUNDING
TABLE 221. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 222. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET: LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Bayers AG
  • Boehringer Ingelheim International GmbH
  • Endo International, Inc.
  • Glaxosmithkline PLC
  • Hisamitsu Pharmaceutical Co., Inc.
  • IBSA Farmaceutici Italia Srl
  • Johnson & Johnson
  • Katecho, LLC
  • Lavipharm S.A.
  • Lead Chemical Co.,Ltd.
  • Luye Pharma Group
  • Manchester BIOGEL
  • Nitto Denko Corporation
  • Novartis International AG
  • Nutriband Inc.
  • Sparsha Pharma International Pvt. Ltd.
  • UCB S.A.
  • Viatris Inc.

Methodology

Loading
LOADING...